Jul
13
Valeant Falls as Investor Left Says He’s Sold It Short Again
By-
‘Small short position, nothing substantial,’ Left says
-
Stock down as much as 6.3 percent after TheStreet.com report
Valeant Pharmaceuticals International Inc. fell Wednesday after investor Andrew Left said he’s taken a new short position in the company.
The shares fell as much as 6.3 percent, reversing gains earlier in the day, and were down 5.6 percent to $21.91 at 3:19 p.m. in New York. Left runs the firm Citron Research, and his short position was first reported by TheStreet.com.
“I have a small short position, nothing substantial, it’s been a few weeks,” he said in a telephone interview. In the interview with TheStreet.com on Wednesday, Left was quoted saying that he thought the stock would eventually be worth nothing…
Valeant Falls as Investor Left Says He’s Sold It Short Again
